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ABSTRACT 
Lichen planus is a mucocutaneous inflammatory disease of unknown etiology. 
Hyperkeratosis, focal hypergranulosis, damage to the basal cell layer, and band-
like infiltrate are hallmarks of LP skin. Lichen sclerosus is a lymphocyte-
mediated dermatosis that has a predilection for the genital skin in both sexes. 
Both pathologies are sharing a number of common characteristics. Previous 
studies have reported on involvement of matrix metalloproteinases and their 
capability of digesting extracellular matrix and basement membrane compo-
nents. We report on the clinical examination of 11 lichen planus patients and 5 
lichen sclerosus patients and the morphological evaluation of their skin biopsy 
samples. Clinical and routine light microscopy findings correlate with the 
literature data. By contrast, the expression of MMP-9 was greatly varying 
among clinical types of cutaneous lichen ruber planus. There was similarity in 
the MMP-9 expression observed between lichen planus pemphigoides and 
lichen sclerosus. 
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INTRODUCTON 
Lichen planus (LP) is a mucocutaneous inflammatory disease of unknown 
etiology [1]. LP shares common chracteristics with the lupus erythematosus, 
benign lichenoid keratosis, keratosis lichenoides chronica, lichen notidus, and     |  177 
lichen sclerosus (LS) lesions. These pathologies are characterized by the 
damage of epidermis appearing mostly in the basal cell layer, and dermal infilt-
ration. Lichen sclerosus is a lymphocyte-mediated dermatosis that has a pre-
dilection for the genital skin in both sexes. LP and LS are usually diagnosed 
c l i n i c a l l y  [ 2 ] .  L P  i s  c h a r a c t e r i z e d  b y  f l a t - t o p p e d ,  p i n k  t o  v i o l a c e o u s ,  s h i n y ,  
pruritic polygonal papules that may coalesce into plaques. The typical clinical 
picture of LS is characterized by whitish, ivory or porcelain-white, sharply 
demarcated, pruritic, individual papules that may become confluent and form 
plaques [3]. The aetiology of both diseases is uncertain [4]. The histologic 
examination of skin or mucosal biopsy is helpful in the cases where there is 
some clinical doubt about the diagnosis and in the documentation of atypical 
features. The classical histological features of LS include a thinned epidermis 
with hyperkeratosis, a wide band of homogenized collagen below the dermo-
epidermal junction and a lymphocytic infiltrate beneath the homogenized area 
[5]. Histologically, LP is characterized by basal layer vacuolization, acanthosis, 
hypergranulosis, and a lymphocytic infiltrate mostly localized at the dermal-
epidermal interface [6]. The lesions usually involve skin, the oral mucous 
membranes, and genitalia. Direct immunofluorescence studies may be helpful 
in the disease differentiation for the cases with no specific clinical or histologic 
characteristics, or with ambiguous features of other diseases [7]. The matrix 
metalloproteinases (MMPs) are a large family of zinc-dependent endopep-
tidases, which are capable of digesting extracellular matrix and basement memb-
rane components. These enzymes can be produced by several types of cells in 
skin such as fibroblasts, keratinocytes, macrophages, lymphocytes, endothelial 
cells, mast cells, and eosinophils [8]. The MMPs are involved in many 
processes including cell proliferation, differentiation, migration, apoptosis, and 
angiogenesis. Previous studies [9] have shown that dermal inflammatory cells 
are strongly expressing MMP-9. The elucidation of the role of MMPs in 
pathogenesis of chronic dermatosis, in general, and LP, in particular, is far from 
definitive. The comparative evaluation of the clinical and pathomorphological 
features of LP and LS including the peculiarities related to the expression of 
MMP-9 in LS and various types of LP appears under the scope of this paper. 
 
 
MATERIALS AND METHODS 
Our target patients were at least 18 years old, suffering from LP or LS for at 
least 4 weeks, having visible characteristic LP or LS eruptions in typical locali-
zation sites. We selected 11 patients (7 female and 4 male patients) with the 
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histologically confirmed diagnosis of LP and 5 patients (all the patients were 
females) with the histologically confirmed diagnosis of LS. All the patients 
were admitted and treated at the Clinical Centre for Skin and Sexually Trans-
mitted Diseases, Riga, Latvia between February 2010 and February 2012. 
Punch biopsy tissues archived at the above mentioned Centre were examined 
using light microscopy. At the time of biopsy all the patients were off any 
topical or systemic LP or LS medication. Study procedures were conducted in 
accordance with the rules of the Ethical Committee. 
Histological sections of 4–5 μm were cut from formalin-fixed, paraffin-
embedded punch biopsy tissues and mounted on slides. Consecutive sections 
were used as negative controls of the immunohistochemical reactions and for 
hematoxylin and eosin (H&E) staining to confirm the diagnosis. For immuno-
chemistry paraffin sections were dewaxed and transferred to a methanol/0.3% 
hydrogen peroxide solution in order to abolish endogenous peroxidase activity. 
After quenching of endogenous peroxidase activity sections were washed three 
times in double distilled water. Heat-induced antigen retrieval was accomp-
lished with the sections placed in 10mM citrate buffer for 30 minutes in a vapor 
lock. After antigen retrieval, specimens were allowed to cool for 20 minutes. 
Nonspecific binding was blocked with 1% bovine serum albumin/5% normal 
goat serum in phosphate buffered saline. Thereafter, sections were incubated at 
4°C overnight with the primary antibody(anti-MMP-9) at a dilution 1:50, and 
next day, with secondary biotinylated antibody (1:500 dilution) for 30 min and 
streptavidin-biotin-peroxidase preformed complex (1:250 dilution) for 30 min. 
The immunological reaction was developed with 3, 3’-diaminobenzidine 
tetrahydrochloride (50 mg in 100 ml of PBS with 0.03% v/v hydrogen 
peroxide). Sections were counterstained with Harrys haematoxylin and 
mounted in Kaiser’s glycerol gelatin. The intensity of immunostaining was 
graded semiquantitatively using the following scale: (0) – negative expression, 
(+) – a weak expression of MMP-9, (++) – a moderate expression of MMP-9 
and (+++) – an intense MMP-9 expression.  
  
 
RESULTS 
Small, flat-topped, shiny, polygonal, violaceous papules were limited to the 
flexor surfaces of the forearms, the legs, the back of the trunk and submammary 
folds. Histologically, the hypertrophic variant of LP, LP pemphigoides and 
follicular form of lichen planus were confirmed. Hypertrophic (three cases) 
appeared to be a common variant which consisted of thickened plaques and     |  179 
showed hyperkeratosis, focal hypergranulosis, basal cell layer degeneration, and 
a band-like subepidermal infiltration (Figure 1). LP pemphigoides (five cases) 
showed bullae arising from papules and normal appearing skin. There were a 
focus of epidermal thickening with liquefaction degeneration of the basal layer, 
a lichenoid inflammatory infiltrate, and, sometimes, fibrin deposition (Figure 
2). Lichen follicularis (three cases) revealed dilated hair follicles containing 
keratotic plugs (Figure 3). There were rather dense chronic inflammatory 
infiltrates in the close vicinity to the hair follicles, and band-like infiltrates 
beneath the epidermis. In LS were observed hyperkeratosis with follicular 
plugging, the atrophy of the stratum malpighii with the hydropic degeneration 
of basal cells, lymphedema and the homogenization of the collagen in the 
upper dermis, an inflammatory infiltrate in the mid-dermis, and the homo-
genization and swelling of the collagen bundles in the lower dermis (Figure 4).  
MMP-9 expression was observed to be greatly varying among the cases 
enrolled in this study (Table 1). In a hypertrophic variant moderate to intense 
expression of metalloproteinase was revealed within the basal and suprabasal 
location of the stratum spinosum (Figure 5). A diffuse and strong MMP-9 
immunostaining throughout all epidermal layers was noticed in the follicular 
variant of LP (Figure 6). The first two types of LP demonstrated diffuse and 
intense MMP-9 immunostaining in dermal lymphohistiocytic infiltrate, hair 
follicle and dermal sweat glands. By contrast, LP pemphigoides (Figure 7) 
demonstrated a weak expression of MMP-9 to the basal layer of epidermis 
whereas intense expression in dermal lymphohistiocytic infiltrate. LS de-
monstrated mild epidermal anti-MMP-9 decoration, which became moderate 
in dermal lymphohistiocytic infiltrate, and intense in sweat glands (Figure 8). 
In LS inflammatory infiltrates occupied mid-dermis region comparing with 
subepidermal characteristic for LP. Moreover, LS showed anti-MMP-9 deco-
ration related to collagen location. 
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Figure 1. Hypertrophic LP with hyperkeratosis, hypergranulosis, saw-tooth profile of rete 
ridges, the degeneration of the basal cell layer, and compact band-like infiltrate below the 
epithelium. H&E, original magnification × 100. 
 
 
Figure 2. LP pemphigoides showing the separation of the epidermis from the dermis. A 
subepidermal bulla overlying a perivascular infiltrate, characteristic of LP pemphigoides. 
The liquefaction degeneration of the basement membrane. H&E, original magnification × 
100. 
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Figure 3. Follicular LP with the basal cell degeneration and subepidermal infiltrate. H&E, 
original magnification × 100. 
 
 
Figure 4. LS revealing hyperkeratosis and hypergranulosis, the atrophy of the stratum 
malpighii with the hydropic degeneration of basal cells, lymphedema and the homo-
genization of the collagen in the upper dermis, as well as a certain number of pigment 
cells. H&E, original magnification × 200. 
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Table 1. Expression of MMP-9 in various clinical types of cutaneous LP and LS. 
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Hypertrophic lichen 
planus 
0/+ 0  ++/ 
+++ 
++/ 
+++ 
+++ +++  0  ++ +++ 
Follicular lichen 
planus 
0 0 ++/ 
+++ 
++/ 
+++ 
+++ +++  0  +  +++ 
Lichen planus 
pemphigoides 
0 0 0/+ +  +++  ++  0  0/+  +/++ 
Lichen sclerosus  0  0  0/+  +/++ +++  0/+  0  0/+  +++ 
 
 
 
Figure 5. Expression of MMP-9 in hypertrophic LP appearing through the malpighii layer, 
dermal infiltrates, vascular beds, and sweat glands; original magnification × 100. 
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Figure 6. Epidermis and hair follicles appearing to be heavily decorated with the anti- 
MMP-9 antibody in the follicular variant of LP, original magnification × 100. 
 
 
Figure 7. Mild epidermal and strong expression of MMP-9 in the inflammatory infiltrate 
demonstrated in LP, original magnification × 200. 
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Figure 8. Mild epidermal and strong expression of MMP-9 in the inflammatory infiltrate 
localized in the mid-dermisin case of LS, original magnification × 100. 
 
 
DISCUSSION 
We performed a complex clinical and pathomorphological study on the skin 
punch biopsy tissue with the confirmed LP diagnosis, and compared them with 
LS biopsy tissue samples. We found that an addition of immunohistochemistry 
data was more relevant and instructive as compared with solely used methods 
and examinations. 
Our evidence regarding the contribution of MMPs to the events underlying 
these cutaneous pathologies is important for further understanding of intimate 
pathways of pathogenesis of LP. 
We demonstrated the moderate and unregulated epidermal expression of 
MMP-9 in the hypertrophic and follicular variants of LP. Our findings suggest 
that the action of MMP-9 is directed toward epidermal/dermal interface, and 
the cells of inflammatory infiltrates localized subepidermally keep a strong 
action potential regarding remodeling of the extracellular matrix and basement 
membrane components. Differences in MMP-9 expression related to colla-
genous structures clearly appeared in the cases of LS that are characterized by 
other events underlying the pathogenesis of this dermatosis. The results of the 
present study suggest that immunologic mechanisms may play a crutial role in 
the pathogenesis of LP. Our results are in accordance with the data reported by 
G u n d u z  [ 9 ] .  I t  s e e m s  t h a t  i n f l a m m a t o r y  c e l l s  a r e  c o n s t a n t  p r o d u c e r s  o f        |  185 
MMP-9 in LP. Moreover, the application of immunohistochemical technique 
allowed us to suggest that inflammatory cells are placed in the close vicinity to 
the vascular beds, which, in turn, are somehow involved in cell migration, and, 
probably, the further induction of the transformation of the perivascular 
extracellular matrix. Semiquantitative scoring of MMP-9 expression was 
helpful in estimation of greatly varying patterns of immunostaining revealed 
among the cases used in this study. The same approach has been reported in a 
few the cases published previously [9]. Lowering of MMP-9 expression in the 
c a s e  o f  L P  p e m p h i g o i d e s  c a n  b e  e x p l a i n e d  b y  t h e  s e v e r e  d a m a g e  o f  t h e  
keratinocytes within the stratum malpighii due to bulla formation, still the 
inflammatory infiltrate appeared to be heavily stained. Sweat glands constantly 
showed rather strong MMP-9 expression. In this case explanation can be based 
on developmental peculiarities when glands and surface epithelium are sharing 
common characteristics. Still, other explanations may appear from further 
studies. The analysis of the literature available shows that the enzymatic re-
modeling caused by MMP-9 has been studied exploring the role of MMPs in 
the cancerization of oral lichen planus [10]. It has been proved that the risk of 
cutaneous LP [11] or LS malignizations is very small compared with mucosal 
involvement [12]. More studies are needed to elucidate the role of MMP-9 in 
malignancy.  
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